Étiquette : hiv

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder ?, Ben SESSA, 2017

Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder ? Ben SESSA Journal of Psychedelic Studies, 2017,  1, (1), pp. 1–9 DOI: 10.1556/2054.01.2016.003   Treating people with alcohol use disorder has been an important target area for psychedelic research – both in the first studies of the 1950s and during the Psychedelic Renaissance of the last 10 years. To date, most studies have looked at the classical psychedelic drugs as adjuncts to psychotherapy; with attention paid to the psychospiritual aspect of the experience as a central therapeutic process in effecting abstinence from drinking. Psychotherapy assisted with 3,4,-methylenedioxymethamphetamine (MDMA) has never been explored for treating [...]

Lire la suite

Bibliographie Cannabinoïdes et HIV/SIDA

Dr Christian Sueur, GRECC, août 2018. ABRAMS D.I., HILTON J.F., LEISER R.J. et al. : Short-term effects of cannabinoids in patients with HIV-1 infection : a randomized, placebo-controlled clinical trial, Annals of Internal Medicine, 2003, 139, 258-266. ABRAMS D.I., JAY C.A. et al : Cannabis in painful HIV-associated sensory neuropathy : a randomized placebo-controlled trial, Neurology, 2007, 68, 7, 515-521. ABRAMS D.I., COUEY P., SHADE S.B. et al. : Cannabinoid-Opioid Interaction in Chronic Pain, Clinical Pharmacology and Therapeutics, 2011, DOI : 10.1038/clpt.2011.188. AVRAHAM H.K. et al. : Impaired Neurogenesis by HIV-1-GP120 is rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme, British Journal of Pharmacology, 2014. [...]

Lire la suite

Le Cannabis et les cannabinoïdes dans les pathologies HIV/SIDA

Dr Christian SUEUR, psychiatre, GRECC (Groupe de Recherches et d’Etudes Cliniques sur les Cannabinoïdes) Août 2018   Dès 1999, dans le rapport « Marijuana and Medicine : Assessing the Science Base », l’Académie de Médecine américaine affirmait le caractère thérapeutique du cannabis chez les patients atteints du SIDA : « The profile of cannabinoid drugs effects suggest that they are promising for treating wasting syndrome in AIDS patients. Nausea, appetite loss, pain and anxiety are all afflictions of wasting, and all can be mitigated by marijuana. Although some médications are more effective than marijuana for these problems, they are not equally effective in all patients. A rapid-onset (that [...]

Lire la suite